June 10, 2014 | Thornton Law Firm Share: Posted by Marilyn M. McGoldrick on Jun 10, 2014 1:13:17 PM Using the diabetes drug Actos for one year or more increases the risk of being diagnosed with bladder cancer by 39% according reports reviewed by the FDA in 2011. Even though the diabetes drug Actos (generic name: pioglitazone) has been taken off the market by the drug regulators of Germany, France, and India because of safety concerns, The Food and Drug Administration (FDA), despite issuing several safety communications about the drug, still allows Actos to be marketed in the United States. The FDA continues to evaluate the data. If you have been diagnosed with bladder cancer after taking Actos, you may still have the ability to bring an Actos lawsuit. You should contact an attorney immediately to evaluate your legal options. Bellwether (test case) trials have already begun against Takeda and Eli Lilly. Thornton Law Firm has assembled a team of Boston Actos lawyers led by partner Marilyn McGoldrick to pursue claims against the manufacturer of Actos, Takeda Pharmaceuticals, Inc., and the company that co-marketed Actos in the United States for many years, Eli Lilly & Co. If you believe you developed bladder cancer after taking Actos, please tell us your story here or call 1-888-491-9726 for a free, confidential evaluation of your claim. You have legal rights, and those rights have strict time limits. Do not delay seeking legal advice.